
Nishan Chobanian Jr. MD
Gynecologic Oncology
Director, Gynecologic Oncology and Robotic Surgery Mercy St Louis
Join to view full profile
26850 Providence PkwySte 530Novi, MI 48374
Phone+1 248-662-4399
Fax+1 248-849-8108
Dr. Chobanian is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Kentucky College of MedicineFellowship, Gynecologic Oncology, 2004
Wright State UniversityResidency, Obstetrics and Gynecology, 1992 - 1996
The Warren Alpert Medical School of Brown UniversityClass of 1992
Certifications & Licensure
ME State Medical License 2022 - 2028
MT State Medical License 2025 - 2027
MI State Medical License 2016 - 2023
MO State Medical License 2007 - 2017
MA State Medical License 2006 - 2011
OH State Medical License 1995 - 2007
KY State Medical License 2001 - 2005
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2016
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Publications & Presentations
PubMed
- 3 citationsMetastatic brain disease in early stage ovarian cancer: A case report.Sophia Halassy, Katrina Au, Nishan Chobanian
Gynecologic Oncology Reports. 2020-01-30 - 8 citationsOvarian cancer.Nishan Chobanian, Charles S Dietrich 3rd
The Surgical Clinics of North America. 2008-04-01 - 43 citationsHistone Deacetylase Inhibitors Enhance Paclitaxel-induced Cell Death in Ovarian Cancer Cell Lines Independent of p53 StatusNishan H Chobanian, Victoria L. Greenberg, Jennifer M Gass, Christopher P. DeSimone, John R. van Nagell
Anticancer Research. 2004-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









